205 related articles for article (PubMed ID: 23406927)
1. HAE update: epidemiology and burden of disease.
Bernstein JA
Allergy Asthma Proc; 2013; 34(1):3-6. PubMed ID: 23406927
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.
Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G
Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514
[TBL] [Abstract][Full Text] [Related]
3. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007.
Zilberberg MD; Jacobsen T; Tillotson G
Allergy Asthma Proc; 2010; 31(6):511-9. PubMed ID: 20964950
[TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema: Epidemiology and burden of disease.
Lumry WR; Settipane RA
Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S08-S13. PubMed ID: 33109318
[TBL] [Abstract][Full Text] [Related]
5. The burden of illness in patients with hereditary angioedema.
Banerji A
Ann Allergy Asthma Immunol; 2013 Nov; 111(5):329-36. PubMed ID: 24125136
[TBL] [Abstract][Full Text] [Related]
6. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.
Lumry WR; Castaldo AJ; Vernon MK; Blaustein MB; Wilson DA; Horn PT
Allergy Asthma Proc; 2010; 31(5):407-14. PubMed ID: 20929608
[TBL] [Abstract][Full Text] [Related]
7. HAE update: determining optimal patient specific therapy.
Gower RG
Allergy Asthma Proc; 2013; 34(1):7-12. PubMed ID: 23406928
[TBL] [Abstract][Full Text] [Related]
8. The new era of C1-esterase inhibitor deficiency therapy.
Tourangeau LM; Zuraw BL
Curr Allergy Asthma Rep; 2011 Oct; 11(5):345-51. PubMed ID: 21833753
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
10. Economic costs associated with acute attacks and long-term management of hereditary angioedema.
Wilson DA; Bork K; Shea EP; Rentz AM; Blaustein MB; Pullman WE
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):314-20. PubMed ID: 20408341
[TBL] [Abstract][Full Text] [Related]
11. Current state of hereditary angioedema management: a patient survey.
Banerji A; Busse P; Christiansen SC; Li H; Lumry W; Davis-Lorton M; Bernstein JA; Frank M; Castaldo A; Long JF; Zuraw BL; Riedl M
Allergy Asthma Proc; 2015; 36(3):213-7. PubMed ID: 25976438
[TBL] [Abstract][Full Text] [Related]
12. Optimizing hereditary angioedema management through tailored treatment approaches.
Nasr IH; Manson AL; Al Wahshi HA; Longhurst HJ
Expert Rev Clin Immunol; 2016; 12(1):19-31. PubMed ID: 26496459
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency.
Bygum A; Fagerberg CR; Ponard D; Monnier N; Lunardi J; Drouet C
Allergy; 2011 Jan; 66(1):76-84. PubMed ID: 20804470
[TBL] [Abstract][Full Text] [Related]
15. Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.
Riedl MA; Craig TJ; Banerji A; Aggarwal K; Best JM; Rosselli J; Hahn R; Radojicic C
Allergy Asthma Proc; 2021 May; 42(3):S17-S25. PubMed ID: 33980329
[TBL] [Abstract][Full Text] [Related]
16. Report on the First Survey of Iranian Patients with Hereditary Angioedema.
Shahinpour S; Tavakol M; Abolhassani H; Mohammadinejad P; Movahedi M; Arshi S; Aghamohammadi A
Iran J Immunol; 2015 Sep; 12(3):209-18. PubMed ID: 26412639
[TBL] [Abstract][Full Text] [Related]
17. Meeting the challenges and burdens associated with hereditary angioedema.
Toscani M; Riedl M
Manag Care; 2011 Sep; 20(9):44-51. PubMed ID: 21991862
[TBL] [Abstract][Full Text] [Related]
18. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
19. Type I and Type II Hereditary Angioedema: Clinical and Laboratory Findings in Iranian Patients.
Kargarsharif F; Mehranmehr N; Zahedi Fard S; Fazlollahi MR; Ayazi M; Mohammadzadeh I; Nabavi M; Bemanian MH; Fayezi A; Movahedi M; Heidarzadeh M; Kalantari N; Arefimehr S; Saghafi S; Pourpak Z
Arch Iran Med; 2015 Jul; 18(7):425-9. PubMed ID: 26161706
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
Mendivil J; Murphy R; de la Cruz M; Janssen E; Boysen HB; Jain G; Aygören-Pürsün E; Hirji I; Devercelli G
Orphanet J Rare Dis; 2021 Feb; 16(1):94. PubMed ID: 33602292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
